Medicine and Dentistry
Airway Obstruction
20%
Benralizumab
30%
Cancer Registry
30%
Carcinoma
30%
Chemoradiotherapy
37%
Clinical Trial
30%
Cooperation
30%
Disease
49%
Dysplasia
30%
Epithelial Dysplasia
30%
Epithelium Hyperplasia
30%
Esophageal Cancer
30%
Esophagectomy
30%
Gynecology
20%
Head and Neck Cancer
60%
Head and Neck Carcinoma
30%
Human Papillomavirus Type 16
30%
in Situ Hybridization
30%
Induction Chemotherapy
20%
Infusion Therapy
30%
Internal Jugular Vein
30%
Intraarterial Drug Administration
30%
Intrapartum
30%
Laryngeal Cancer
30%
Meningioma
30%
Molecular Pathology
30%
Neck Cyst
20%
Neoplasm
24%
Observational Study
30%
Obstetrics
20%
Occupation (Patient Social Context)
30%
Oropharyngeal Cancer
30%
Oropharynx Squamous Cell Carcinoma
69%
Overall Survival
20%
P16
47%
Parotid Gland Cancer
30%
Parotidectomy
20%
Pharynx Cancer
30%
Phonation
37%
Prevalence
32%
Proliferating Cell Nuclear Antigen
30%
Radiation Therapy
28%
Retrospective Study
30%
Rhinosinusitis
30%
Robot-Assisted Surgery
30%
Subtotal Thyroidectomy
20%
Thyroglossal Duct
30%
Tracheotomy
45%
Vocal Folds
60%
Wart Virus
63%
Keyphrases
Aerodynamic Characteristics
30%
Auditory Meatus
9%
Base Region
30%
Benralizumab
30%
Cervical Cyst
12%
Cervical Trauma
30%
Coccobacilli
30%
Digestive Reconstruction
30%
Dupilumab
12%
Emended Description
30%
Eosinophilic Otitis Media
30%
Ex Utero Intrapartum Treatment
30%
External Ear
9%
FaDu
15%
Head-and-neck Cancer
30%
High Efficiency
9%
HPV16 E7
30%
Human Clinical Specimen
30%
Human Neck
30%
Infusion Therapy
30%
Intra-arterial Infusion
30%
Mediastinal Emphysema
9%
Mepolizumab
18%
Mild Dysplasia
30%
Moderate Dysplasia
30%
Mucoepidermoid Carcinoma
9%
Oral Tongue Squamous Cell Carcinoma (OTSCC)
30%
Oropharyngeal Squamous Carcinoma
30%
P16-positive
30%
Parotid Cancer
30%
Parotid Gland Carcinoma
30%
Parotid Gland Tumor
9%
Parotid Region
9%
Parotidectomy
9%
Pediatric Thyroid Carcinoma
30%
Piriform Sinus
15%
Pogona Vitticeps
30%
Porphyromonas Pogonae
30%
Purulent Discharge
9%
Real-world Clinical Outcomes
30%
Santorini
30%
Severe Dysplasia
30%
Shah
30%
Super-selective
30%
Thyroglossal Duct
30%
Thyroglossal Duct Carcinoma
30%
Thyroid Capsule
15%
Thyroid Lobectomy
30%
Upper Pole
9%
Vibrational States
9%
Pharmacology, Toxicology and Pharmaceutical Science
Cancer Registry
30%
Chemoradiation Therapy
17%
Cisplatin
12%
Disease
19%
Head and Neck Cancer
30%
Head and Neck Carcinoma
30%
Head and Neck Squamous Cell Carcinoma
5%
Human Papillomavirus
63%
Human Papillomavirus Type 16
30%
Neoplasm
6%
Nerve Paralysis
15%
Nicotinamide Phosphoribosyltransferase
12%
Observational Study
30%
Oropharynx Cancer
45%
Oropharynx Squamous Cell Carcinoma
100%
Overall Survival
15%
Prevalence
32%
Recurrence Free Survival
8%
Squamous Cell Carcinoma
30%
Survival Rate
12%
